Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.26B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$268M |
| 3 |
Baxter International
BAX
|
+$212M |
| 4 |
UnitedHealth
UNH
|
+$185M |
| 5 |
Corteva
CTVA
|
+$169M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 2 |
Microsoft
MSFT
|
+$260M |
| 3 |
Meta Platforms (Facebook)
META
|
+$251M |
| 4 |
Salesforce
CRM
|
+$226M |
| 5 |
Match Group
MTCH
|
+$188M |
Sector Composition
| 1 | Technology | 22.84% |
| 2 | Healthcare | 15.09% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Phibro Animal Health
PAHC
$1.61B
| $4.43M | ﹤0.01% |
333,465
-5,649
| -2% | -$75.1K |
|
1952
Vericel Corp
VCEL
$1.62B
| $4.41M | ﹤0.01% |
190,046
-7,631
| -4% | -$177K |
|
1953
Veracyte
VCYT
$2.43B
| $4.39M | ﹤0.01% |
264,696
-5,245
| -2% | -$87.1K |
|
1954
St. Joe Company
JOE
$3.01B
| $4.39M | ﹤0.01% |
137,011
-48,040
| -26% | -$1.54M |
|
1955
AAR Corp
AIR
$2.67B
| $4.38M | ﹤0.01% |
122,300
-2,856
| -2% | -$102K |
|
1956
ProAssurance
PRA
$1.22B
| $4.36M | ﹤0.01% |
223,575
-6,395
| -3% | -$125K |
|
1957
Arcus Biosciences
RCUS
$1.23B
| $4.36M | ﹤0.01% |
166,675
-4,956
| -3% | -$130K |
|
1958
Griffon
GFF
$3.61B
| $4.36M | ﹤0.01% |
147,621
-5,768
| -4% | -$170K |
|
1959
Entravision Communication
EVC
$226M
| $4.35M | ﹤0.01% |
1,095,820
-22,691
| -2% | -$90.1K |
|
1960
Clean Energy Fuels
CLNE
$526M
| $4.35M | ﹤0.01% |
814,149
-337,478
| -29% | -$1.8M |
|
1961
Univest Financial
UVSP
$886M
| $4.35M | ﹤0.01% |
185,087
-8,348
| -4% | -$196K |
|
1962
First Bancorp
FBNC
$2.29B
| $4.32M | ﹤0.01% |
118,170
-3,321
| -3% | -$121K |
|
1963
Worthington Enterprises
WOR
$3.17B
| $4.32M | ﹤0.01% |
183,716
-5,356
| -3% | -$126K |
|
1964
Cohu
COHU
$964M
| $4.31M | ﹤0.01% |
167,298
-21,216
| -11% | -$547K |
|
|
NVEI
1965
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $4.31M | ﹤0.01% |
115,481
| – | – |
|
1966
Marten Transport
MRTN
$953M
| $4.31M | ﹤0.01% |
224,791
-5,747
| -2% | -$110K |
|
|
NSCS
1967
DELISTED
Nuveen Small Cap Select ETF
NSCS
| $4.3M | ﹤0.01% |
220,000
| – | – |
|
1968
Lyell Immunopharma
LYEL
$246M
| $4.28M | ﹤0.01% |
29,185
-707
| -2% | -$104K |
|
1969
SiTime
SITM
$6.76B
| $4.27M | ﹤0.01% |
54,189
-1,444
| -3% | -$114K |
|
1970
SPDR S&P Biotech ETF
XBI
$5.43B
| $4.25M | ﹤0.01% |
+53,629
| New | +$4.25M |
|
1971
Primoris Services
PRIM
$6.59B
| $4.25M | ﹤0.01% |
261,669
-8,527
| -3% | -$139K |
|
1972
Weis Markets
WMK
$1.75B
| $4.24M | ﹤0.01% |
59,517
-1,495
| -2% | -$107K |
|
1973
Aspen Aerogels
ASPN
$543M
| $4.24M | ﹤0.01% |
459,271
-3,855
| -0.8% | -$35.5K |
|
|
CERE
1974
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $4.22M | ﹤0.01% |
149,411
-69,334
| -32% | -$1.96M |
|
1975
LiveRamp
RAMP
$1.73B
| $4.22M | ﹤0.01% |
232,099
-7,039
| -3% | -$128K |
|